Sarcomatrix Therapeutics To Present Advances In Muscle Disease Drug Development At 2025 BIO CEO & Investor Conference
Sarcomatrix Therapeutics, Corp Logo Company Prepares for Phase 1 Clinical Trials of Lead Candidate S-969 in 2025 Our robust preclin ...
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and ...
Will RBI rethink its policy of banning biz of banks and NBFCs? Seems so, say bankers
Talking extensively about some of the proposed regulatory changes, the RBI governor for the first time went beyond the usual ...
Lionsgate Studios, Starz Split Now Looking Like April At The Earliest – Update
Lionsgate CEO now anticipates the long-awaited split of Studios and Starz shortly after a mid to late-April shareholder ...